Omyaa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 20.00%
- Profit Growth 43.12%
- Ebitda -112.79%
- Net Worth -8.65%
- Total Assets -3.81%
About Omyaa Pharmaceuticals
Omyaa Pharmaceuticals Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 October 2020 (Four years and three months 27 days old ). Its registered office is in South West Delhi, Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Roushan, Om Prakash, and Shailesh Verma serve as directors at the Company.
Company Details
-
Location
South West Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2020PTC371821
-
Company No.
371821
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Omyaa Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Roushan
|
Director | 27-Jul-2022 | Current |
|
Om Prakash
|
Director | 19-Oct-2020 | Current |
|
Shailesh Verma
|
Director | 19-Oct-2020 | Current |
Financial Performance of Omyaa Pharmaceuticals.
Omyaa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20% increase. The company also saw a substantial improvement in profitability, with a 43.12% increase in profit. The company's net worth dipped by a decrease of 8.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omyaa Pharmaceuticals?
Unlock access to Omyaa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Emedinova Marketing Private LimitedRakesh Roushan is a mutual person
-
Namobudham Hospital Private Limited
Rakesh Roushan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Omyaa Pharmaceuticals?
Omyaa Pharmaceuticals has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omyaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omyaa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.